Industry
why Sonnet BioTherapeutics Holdings Inc [SONN] is a Good Choice for Investors After New Price Target of $14.67
Sonnet BioTherapeutics Holdings Inc [NASDAQ: SONN] surged by $0.1 during the normal trading session on while it closed the day at $0.81. Sonnet BioTherapeutics Holdings Inc stock has also gained 9.44% of its value over the past 7 days. However, SONN stock has declined by
